A p53 mutation in exon 5 associated with adenovirus transformation

Y L Eyler1, D F Siwarski, K E Huppi

  • 1Laboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892.

Molecular Carcinogenesis
|January 1, 1995
PubMed

Insights

Adenovirus type 5 (Ad5) E1B oncoprotein usually inactivates p53. However, a p53 mutation was found in an Ad5-transformed cell line, suggesting an alternative inactivation mechanism when E1B protein is low.

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • Adenovirus type 5 (Ad5) E1B 55-kDa oncoprotein forms complexes with the p53 tumor suppressor protein.
  • These complexes are believed to inhibit p53 activity, potentially explaining the rarity of p53 mutations in Ad5-transformed cells.

Purpose of the Study:

  • To investigate the role of p53 mutations in Ad5-transformed cells.
  • To explore alternative mechanisms of p53 inactivation during adenovirus transformation.

Main Methods:

  • Analysis of p53 mutation status in Ad5-transformed cell lines.
  • Comparison of E1B 55-kDa protein expression and tumor-latency phenotypes between Ad5-transformed cell lines.
  • Characterization of a specific p53 mutation in exon 5.

Main Results:

  • A p53 mutation in exon 5 was identified in an Ad5-transformed cell line.
  • This cell line showed reduced E1B 55-kDa protein expression and a prolonged tumor-latency period compared to a line with wild-type p53.
  • The presence of a p53 mutation is unusual given the established role of p53-E1B interactions in Ad5 transformation.

Conclusions:

  • The identified p53 mutation may represent an alternative pathway for p53 inactivation in Ad5-transformed cells.
  • This mechanism could be active when levels of the E1B 55-kDa oncoprotein are insufficient to fully suppress p53 function.
  • Findings challenge the prevailing theory by demonstrating p53 mutation as a viable alternative in Ad5 transformation.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...